PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. HOOD
10. RGNX

Go back to PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

PTC Therapeutics (PTCT) Misses Q4 EPS by $2.55

February 29, 2024 4:16 PM EST

PTC Therapeutics (NASDAQ: PTCT) reported Q4 EPS of ($2.06), $2.55 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $307.1 million versus the consensus estimate of $316.48 million.

GUIDANCE:

PTC Therapeutics sees Q1 2024 revenue of $600-680 million.

PTC... More